HIV postexposure prophylaxis: new recommendations.
Patrick
D M
DM
British Columbia Centre for Disease Control Vancouver, BC.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017848:Blood-Borne Pathogens; D018890:Chemoprevention; D004338:Drug Combinations; D017408:Guidelines as Topic; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006282:Health Personnel; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage / Q000627:therapeutic use; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control*; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D009784:Occupational Diseases / Q000517:prevention & control*; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004338:Drug Combinations; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir